These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
156 related items for PubMed ID: 38482522
1. Dissolving Microneedle-Based Cascade-Activation Nanoplatform for Enhanced Photodynamic Therapy of Skin Cancer. Ma J, Tai Z, Li Y, Li Y, Wang J, Zhou T, Shen M, Xin R, Shen C, Zhu Q, Chen Z. Int J Nanomedicine; 2024; 19():2057-2070. PubMed ID: 38482522 [Abstract] [Full Text] [Related]
2. Anti-LDLR modified TPZ@Ce6-PEG complexes for tumor hypoxia-targeting chemo-/radio-/photodynamic/photothermal therapy. Song C, Xu W, Wei Z, Ou C, Wu J, Tong J, Cai Y, Dong X, Han W. J Mater Chem B; 2020 Jan 28; 8(4):648-654. PubMed ID: 31898718 [Abstract] [Full Text] [Related]
3. Hypoxia and Singlet Oxygen Dual-Responsive Micelles for Photodynamic and Chemotherapy Therapy Featured with Enhanced Cellular Uptake and Triggered Cargo Delivery. Guo X, Han L, Chen W, He H, Zhang W, Huang C, Wang X. Int J Nanomedicine; 2024 Jan 28; 19():247-261. PubMed ID: 38229704 [Abstract] [Full Text] [Related]
4. Cancer-Selective Bioreductive Chemotherapy Mediated by Dual Hypoxia-Responsive Nanomedicine upon Photodynamic Therapy-Induced Hypoxia Aggravation. Zhu R, He H, Liu Y, Cao D, Yan J, Duan S, Chen Y, Yin L. Biomacromolecules; 2019 Jul 08; 20(7):2649-2656. PubMed ID: 31125209 [Abstract] [Full Text] [Related]
5. Controllable hypoxia-activated chemotherapy as a dual enhancer for synergistic cancer photodynamic immunotherapy. Wang M, He M, Zhang M, Xue S, Xu T, Zhao Y, Li D, Zhi F, Ding D. Biomaterials; 2023 Oct 08; 301():122257. PubMed ID: 37531778 [Abstract] [Full Text] [Related]
6. Stepwise-activatable hypoxia triggered nanocarrier-based photodynamic therapy for effective synergistic bioreductive chemotherapy. Ihsanullah KM, Kumar BN, Zhao Y, Muhammad H, Liu Y, Wang L, Liu H, Jiang W. Biomaterials; 2020 Jul 08; 245():119982. PubMed ID: 32224374 [Abstract] [Full Text] [Related]
7. Supramolecular micelles as multifunctional theranostic agents for synergistic photodynamic therapy and hypoxia-activated chemotherapy. Huang X, Chen T, Mu N, Lam HW, Sun C, Yue L, Cheng Q, Gao C, Yuan Z, Wang R. Acta Biomater; 2021 Sep 01; 131():483-492. PubMed ID: 34265471 [Abstract] [Full Text] [Related]
8. Glutathione-Responsive Polymersome with Continuous Glutathione Depletion for Enhanced Photodynamic Therapy and Hypoxia-Activated Chemotherapy. Cheng G, Tao S, Liu S, Wang P, Zhang C, Liu J, Hao C, Wang S, Guo D, Xu B. ACS Macro Lett; 2024 May 21; 13(5):599-606. PubMed ID: 38683197 [Abstract] [Full Text] [Related]
9. Tumor-Penetrating Nanoparticles for Enhanced Anticancer Activity of Combined Photodynamic and Hypoxia-Activated Therapy. Wang Y, Xie Y, Li J, Peng ZH, Sheinin Y, Zhou J, Oupický D. ACS Nano; 2017 Feb 28; 11(2):2227-2238. PubMed ID: 28165223 [Abstract] [Full Text] [Related]
10. Targeted co-delivery of a photosensitizer and an antisense oligonucleotide based on an activatable hyaluronic acid nanosystem with endogenous oxygen generation for enhanced photodynamic therapy of hypoxic tumors. Wu Y, Ding L, Zheng C, Li H, Wu M, Sun Y, Liu X, Zhang X, Zeng Y. Acta Biomater; 2022 Nov 28; 153():419-430. PubMed ID: 36115655 [Abstract] [Full Text] [Related]
11. Photodynamic Therapy with Liposomal Zinc Phthalocyanine and Tirapazamine Increases Tumor Cell Death via DNA Damage. Broekgaarden M, Weijer R, van Wijk AC, Cox RC, Egmond MR, Hoebe R, van Gulik TM, Heger M. J Biomed Nanotechnol; 2017 Feb 28; 13(2):204-20. PubMed ID: 29377650 [Abstract] [Full Text] [Related]
12. Combined Cancer Chemo-Photodynamic and Photothermal Therapy Based on ICG/PDA/TPZ-Loaded Nanoparticles. Huang X, Wu J, He M, Hou X, Wang Y, Cai X, Xin H, Gao F, Chen Y. Mol Pharm; 2019 May 06; 16(5):2172-2183. PubMed ID: 30978027 [Abstract] [Full Text] [Related]
13. Multifunctional Theranostic Liposomes Loaded with a Hypoxia-Activated Prodrug for Cascade-Activated Tumor Selective Combination Therapy. Dai Y, Wang B, Sun Z, Cheng J, Zhao H, Wu K, Sun P, Shen Q, Li M, Fan Q. ACS Appl Mater Interfaces; 2019 Oct 30; 11(43):39410-39423. PubMed ID: 31578854 [Abstract] [Full Text] [Related]
14. A hybrid metal-organic framework nanomedicine-mediated photodynamic therapy and hypoxia-activated cancer chemotherapy. Jia Z, Gao Y, Ni J, Wu X, Mao Z, Sheng G, Zhu Y. J Colloid Interface Sci; 2023 Jan 30; 629(Pt B):379-390. PubMed ID: 36162395 [Abstract] [Full Text] [Related]
15. Targeting triple-negative breast cancer with an aptamer-functionalized nanoformulation: a synergistic treatment that combines photodynamic and bioreductive therapies. Chou YT, Lin CY, Wen JW, Hung LC, Chang YF, Yang CM, Wu LC, Ho JA. J Nanobiotechnology; 2021 Mar 29; 19(1):89. PubMed ID: 33781277 [Abstract] [Full Text] [Related]
16. Engineered biomimetic nanoreactor for synergistic photodynamic-chemotherapy against hypoxic tumor. Guo H, Wang L, Wu W, Guo M, Yang L, Zhang Z, Cao L, Pu F, Huang X, Shao Z. J Control Release; 2022 Nov 29; 351():151-163. PubMed ID: 36122895 [Abstract] [Full Text] [Related]
17. A light and hypoxia-activated nanodrug for cascade photodynamic-chemo cancer therapy. Zhong Y, Huang S, Zheng C, Huang J, Li B, Han S, Xiao H, Wang Y, Shuai X. Biomater Sci; 2021 Jul 27; 9(15):5218-5226. PubMed ID: 34169939 [Abstract] [Full Text] [Related]
18. Hypoxia Induced by Upconversion-Based Photodynamic Therapy: Towards Highly Effective Synergistic Bioreductive Therapy in Tumors. Liu Y, Liu Y, Bu W, Cheng C, Zuo C, Xiao Q, Sun Y, Ni D, Zhang C, Liu J, Shi J. Angew Chem Int Ed Engl; 2015 Jul 06; 54(28):8105-9. PubMed ID: 26012928 [Abstract] [Full Text] [Related]
19. Ce6-C6-TPZ co-loaded albumin nanoparticles for synergistic combined PDT-chemotherapy of cancer. Sun X, Sun J, Lv J, Dong B, Liu M, Liu J, Sun L, Zhang G, Zhang L, Huang G, Xu W, Xu L, Bai X, Song H. J Mater Chem B; 2019 Oct 14; 7(38):5797-5807. PubMed ID: 31483422 [Abstract] [Full Text] [Related]
20. Optimized Combination of Photodynamic Therapy and Chemotherapy Using Gelatin Nanoparticles Containing Tirapazamine and Pheophorbide a. Lee D, Jang SY, Kwon S, Lee Y, Park E, Koo H. ACS Appl Mater Interfaces; 2021 Mar 10; 13(9):10812-10821. PubMed ID: 33624503 [Abstract] [Full Text] [Related] Page: [Next] [New Search]